Blue Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Blue Trust's JAZZ Position: Q3 2026 in Review
Blue Trust reduced its Jazz Pharmaceuticals (JAZZ) stake by 28% in Q3 2026, selling an estimated $208K and leaving 2,119 shares worth $491K. The position accounts for 0.01% of the portfolio, ranked #491.
Blue Trust first reported a position in JAZZ in Q2 2022 and has held it in 16 quarters since. The position peaked at $713K in Q2 2026. 538 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Blue Trust held 2,119 shares of Jazz Pharmaceuticals worth $491K as of Q3 2026.
- Blue Trust sold 842 Jazz Pharmaceuticals shares in Q3 2026, an estimated $208K.
- Jazz Pharmaceuticals made up 0.01% of Blue Trust's portfolio in Q3 2026, its #491 holding.
- Blue Trust first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
- Blue Trust's Jazz Pharmaceuticals position peaked at $713K in Q2 2026.
- 538 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.